This $48 Million Startup Wants To Do What Theranos Couldn't
ฝัง
- เผยแพร่เมื่อ 14 ต.ค. 2024
- The next era of accessible lab testing is here. Meet VitalOne, a compact blood analysis device designed with the latest advances in robotics, biochemistry, computer vision, and microfluidics to deliver lab-grade results in the doctor’s office in minutes. In this session, we see VitalOne in action and learn more from co-founder and CEO Vasu Nadella on where the company is headed.
Speaker: Vasu Nadella, Co-founder and CEO, Vital Biosciences; Moderator: Andrew Nusca, FORTUNE
Subscribe to Fortune -
www.youtube.com...
Fortune Magazine is a global leader in business journalism with 55 million monthly page views and a readership of nearly 32 million, with major franchises including the Fortune 500 and the Fortune 100 Best Companies to Work For. The new Fortune video channel dives into personal stories from business owners and entrepreneurs becoming successful in business and sharing their tips to help you reach your goals.
Website: fortune.com/
Facebook: / fortunemagazine
Twitter: / fortunemagazine
TikTok: / fortune
The need is still there, so it's good that others are continuing to innovate in this space.
Can't let one bad apple spoil the harvest.
Glad to see the Theranos debacle didn't dampen other companies in this space.
Being working in microfluidic make me know this technology is there, many paper research related with it. Just need someone like Vasu to get them together. Good job.
This is groundbreaking, kudos to them for doing it right
Microfluidics has been around for a long time decades. With applications in space already, so there's no stretch of credulity here. I really wonder what happened with theranos because this technology is coming sooner or later from someone.
IIRC, the biggest problem with Theranos was that the blood sample was in fact too small to give you consistent readings about the blood's composition.
This also seems small... But the ideas sound interesting.
Theranos... I think they mostly just sabotaged themselves by setting too high a bar... And then cheating on the demo because they likely thought that they were "almost there".
Like Tesla's FSD having taken so many years... Sometimes, you don't know how hard it's really going to be and how long it'll take.
And you can overcommit to a bad strategy.
Off to a good start by drawing parallel to Theranos.
It will work..
Btw this type of instant blood work in hospitals is called STAT blood work and it already exists.
Not in this form factor though
"What theranos couldn't do?" aka beat the prison sentence and not get caught? lol
Until this type of product becomes open source and approved outside the USA (preferably Europe) I wouldn't be "excited" about what it's advertised to do. Nobody should have to gamble with their health on any "proprietary technology" or the low or broad standards of the FDA.
How precise are these tests and what are the risks of mistake ?
Swiss company btw is working on it since years ans Theranos knew it .....
For me, it is fundamental, if below 90% , its a no go, we have too many gimmick tests on the market in cancer prevention , they have 20-30% accuracies and the only thing they do is collect data as ypu cannot really trust them
At this stage old fashion blood test is absolutely fine, and at least you know it's accurate
They have opened up their cap table to the Theranos investors so that they can recover what they lost.
They shorted the top and got rich, it was a hit job. She was not guilty
How do we know this isn't another Theranos LOL
Glad to see someone getting back into this, lots of room for improvement in blood testing, too bad theranos tainted it for a while.
there is a difference they have a product the other person didn’t
Like, getting away with fraud?
😢😔..
Theranos 2.0 ?
People will fall for this shit so many times lols. You know why? Because they’re looking for places to launder money.
As precise as Covid sticks😊
There are easier ways to go to jail...
He has the dead eyes of a scammer. I do not trust these guys at all.
Same shit different scammers
Nonsense.
When Forbes r writing about it… something is wrong..:😂😂😂